The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
China Medical System Holdings Ltd
F:2M7C
|
CN |
|
N
|
Northern Trust Corp
DUS:NT4
|
US |
|
S
|
Suntrust Resort Holdings Inc
XPHS:SUN
|
PH |
|
U
|
United Therapeutics Corp
SWB:UTH
|
US |
|
W
|
Westinghouse Air Brake Technologies Corp
F:WB2
|
US |
|
Klaveness Combination Carriers ASA
F:36K
|
NO |
|
C
|
Century Aluminum Co
F:EY3
|
US |
|
I
|
i-Components Co Ltd
KOSDAQ:059100
|
KR |
|
S
|
SSE PLC
XMUN:SCT
|
UK |
|
L
|
Lundin Gold Inc
STO:LUG
|
CA |
|
Geberit AG
F:GBRF
|
CH |
|
Akron PAO
MOEX:AKRN
|
RU |
|
Gap Inc
NYSE:GAP
|
US |
|
T
|
Tegna Inc
F:GTT
|
US |
|
Granges AB
F:9GR
|
SE |
|
Blue Owl Capital Corp
F:1D6
|
US |
|
E
|
East Asia Holdings Investment Ltd
KOSDAQ:900110
|
HK |
|
Aerofoam Metals Inc
OTC:AFML
|
US |
|
I
|
International Graphite Ltd
ASX:IG6
|
AU |
|
P
|
PayPal Holdings Inc
SWB:2PP
|
US |
|
Genting Singapore Ltd
SGX:G13
|
SG |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
XMUN:AIL
|
FR |
China Medical System Holdings Ltd (2M7C)’s 12-month stock price forecast through October 2027 has a consensus target of €2.57, implying 134% upside. The forecast is based on price targets from 9 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for 2M7C is 2.57 EUR with a low forecast of 2.12 EUR and a high forecast of 3.01 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 20%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 3 years is 21%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 3 years is 26%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 17%.
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is 23%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more